Connect with us

Asean

Healthcare and the road to Asean Economic Community (AEC) in 2015

The AEC aims to make Asean a single market and production base, with a free flow of goods, services, investment, skilled labour and freer flow of capital. This will pose major challenges, as well as increased opportunities, for Thai stakeholder

Avatar

Published

on

Bangkok Hospital

As Asean members prepare for regional integration under the Asean Economic Community (AEC) in 2015, stakeholders in Thailand’s healthcare industry need to consider many issues in order to take full advantage of the opportunities.

The AEC aims to make Asean a single market and production base, with a free flow of goods, services, investment, skilled labour and freer flow of capital. This will pose major challenges, as well as increased opportunities, for Thai stakeholders. They will need to reposition themselves as effective and efficient operators within Asean as a whole and not simply within Thailand.

Harmonisation of pharmaceutical registration: Healthcare is one of 12 service industries to be liberalized under the AEC. The commitment to a single market and production base requires, among other things, tariff liberalization, removal of non-tariff barriers, harmonisation of product standards and technical regulations, and mutual recognition of test reports and certification.

Bangkok Hospital

Healthcare and the road to Asean Economic Community (AEC) in 2015

To this end, through the Asean Pharmaceutical Product Working Group, member countries have started implementing the Asean Harmonisation on Pharmaceutical Registration. Under these new rules, Asean pharmaceutical manufacturers (and manufacturers outside Asean wishing to export their products into Asean) are required to prepare application dossiers in a common format in accordance with the guidelines of the Asean Common Technical Requirement (ACTR) on safety, quality and efficacy and the Asean Common Technical Dossier (ACTD) on other details.

The ACTR guidelines cover analytical validation, bio-availability and bio-equivalent studies (BA/BE), process validation, and stability data that comply with the standards set forth in the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines.

The Thai Food and Drug Administration (FDA) has implemented the Asean Harmonisation rules voluntarily since 2008. These rules became effective on Jan 1, 2009.

The harmonisation rules will have an impact on both importers and manufacturers whose drug application dossiers have not been prepared in accordance with Asean guidelines (known as non-Asean drugs). Under the Thai Drug Act, B.E. 2522 (revised edition), drug application dossiers that were registered and received certificates before the Act came into effect could have been used until the expiration of the term of the certificate. This, in effect, meant a life-long certificate, since no expiry date was specified, unlike other countries where a five-year validity is the norm. Therefore, for drugs registered before Jan 1, 2009, the application dossiers will have to be adjusted in compliance with the Asean guidelines.

Furthermore, once the AEC takes effect, all pharmaceutical manufacturing premises in the region must comply with the Pharmaceutical Inspection Convention and Pharmaceutical Cooperation Scheme (PIC/S). Upgrading premises to meet PIC/S requirements should improve Thailand’s attractiveness as an investment location, but will also involve substantial costs and may have a significant impact on small and medium operators.

Excerpt from :

Healthcare and the road to asean integration

Comments

Asean

The Latest on Covid-19 in Southeast Asia

Thailand has largely avoided widespread community transmission of Covid-19, but the kingdom is not faring well on the economic front, with a projected contraction of 7.1 percent this year.

Avatar

Published

on

Coronavirus Asia

As a region, Southeast Asia has fared relatively well in keeping coronavirus cases low, with the notable exceptions of the Philippines and Indonesia.

(more…)
Continue Reading

Laos

China’s debt-trap diplomacy: Laos’ credit rating downgraded to CCC

Laos’ debt challenge is deeply concerning, with some media commentators suggesting the country is falling into a debt trap as a result of Chinese infrastructure investments connected to the Belt and Road Initiative (BRI)

Boris Sullivan

Published

on

On 23 September, the Fitch Ratings agency downgraded Laos’ credit rating to CCC — the second downgrade in 2020, having dropped to B- in May.

(more…)
Continue Reading

Vietnam

Foreign capital still heads to Vietnam

As many as 798 projects added a combined over 5.11 billion USD to their investment capital, down 23 percent year-on-year in project number but up 6.8 percent in value.

Avatar

Published

on

Hanoi (VNA) – The total amount of foreign investment poured into Vietnam this year to September 20 reached 21.2 billion USD, equivalent to 81.8 percent of the same period last year, reported the Ministry of Planning and Investment.

(more…)
Continue Reading

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,609 other subscribers

Trending